Personalized brain cancer vax tested in humans

An experimental brain cancer vaccine developed at Duke University is being tested on patients at Duke and St. Vincent's Medical Center in Jacksonville, FL. The vaccine is made by extracting white blood cells from the patient and then mixing it with DNA that includes the genetic mutations that triggered the glioblastoma. "We think a significant reason these tumors are so hard to treat to begin with is they are so good at evading the immune system," said Kent New, the head of neurosurgery at an affiliate of St. Vincent's. New trained with Duke's John Sampson, who developed the personalized vaccine. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.